![](https://endpts.com/wp-content/uploads/2020/01/stencil.twitter-post-2-scaled.jpg)
File photo
Alexis Borisy has $200M to back a market-based plan aimed at curing America’s drug pricing ‘sickness’
SAN FRANCISCO — As a high-profile figure in the biotech boom that has transformed the industry over the last decade, Alexis Borisy co-founded a slew of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.